(Q57374840)

English

Short-Term Administration of a Cell-Permeable Caveolin-1 Peptide Prevents the Development of Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy

article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Short-Term Administration of a Cell-Permeable Caveolin-1 Peptide Prevents the Development of Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy (English)

0 references

main subject

right ventricular hypertrophy

1 reference

based on heuristic

inferred from title

pulmonary hypertension

1 reference

5

Michael P. Lisanti

0 references

Herbert B Tanowitz

series ordinal

4

object named as

Herbert B. Tanowitz

0 references

author name string

Jean-François Jasmin

series ordinal

1

0 references

Isabelle Mercier

series ordinal

2

0 references

Jocelyn Dupuis

series ordinal

3

0 references

language of work or name

English

0 references

publication date

29 August 2006

0 references

published in

Circulation

0 references

volume

114

0 references

issue

9

0 references

page(s)

912-920

0 references

cites work

Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1074/JBC.M105408200

Identifiers

DOI

10.1161/CIRCULATIONAHA.106.634709

0 references

PubMed ID

16940204

0 references

(Q57374840)

Short-Term Administration of a Cell-Permeable Caveolin-1 Peptide Prevents the Development of Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)